These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2140510)

  • 1. Glucosyl phosphotriesters of nucleosides: exchange mechanism of transmembrane transport and application to 5-fluoro-deoxyuridine.
    Debouzy JC; Hervé M; Neumann JM; Gouyette C; Dupraz B; Huynh-Dinh T
    Biochem Pharmacol; 1990 Jun; 39(11):1657-64. PubMed ID: 2140510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and tumor uptake of 5-82Br- and 5-131I-labeled 5-halo-1-(2-fluoro-2-deoxy-beta-D-ribofuranosyl)uracils.
    Mercer JR; Xu LH; Knaus EE; Wiebe LI
    J Med Chem; 1989 Jun; 32(6):1289-94. PubMed ID: 2524593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complementary addressed modification of nucleic acids with the alkylating derivatives of oligothymidylate ethyl phosphotriesters. Effect of the phosphotriester fragments' configuration.
    Abramova TV; Vlassov VV; Lebedev AV; Ryte AS
    FEBS Lett; 1988 Aug; 236(1):243-5. PubMed ID: 2456955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Fluorouracil derivatives. III. A simple method to prepare 5-fluoro-2'-deoxyuridine derivatives.
    Ozaki S; Watanabe Y; Hoshiko T; Ii S; Kagawa T
    Nucleic Acids Symp Ser; 1983; (12):9-12. PubMed ID: 6229716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of 2'-halogeno-2'-deoxyuridines with the human erythrocyte nucleoside transport mechanism.
    Gati WP; Knaus EE; Wiebe LI
    Mol Pharmacol; 1983 Jan; 23(1):146-52. PubMed ID: 6223203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleoside conjugates. 8. The preparation of 5-fluoro-2'-deoxyuridine conjugates of corticosteroids.
    An SH; West CR; Hong CI
    Steroids; 1986 Jun; 47(6):413-20. PubMed ID: 2956735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonclassical antimetabolites. XXV. Inhibitors of thymidine kinase. I. A new spectrophotometric assay. Inhibition by nucleoside derivatives.
    Baker BR; Schwan TJ; Santi DV
    J Med Chem; 1966 Jan; 9(1):66-72. PubMed ID: 4225176
    [No Abstract]   [Full Text] [Related]  

  • 8. X-ray structure of 3',5'-diacetyl-2'-deoxy-2'-fluorouridine: a pyrimidine nucleoside in the syn conformation.
    Suck D; Saenger W; Main P; Germain G; Declercq JP
    Biochim Biophys Acta; 1974 Sep; 361(3):257-65. PubMed ID: 4279089
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis and tumor uptake of 5-halo-1-(2'-fluoro-2'-deoxy-beta-D-ribofuranosyl)[2-14C]uracils.
    Mercer JR; Knaus EE; Wiebe LI
    J Med Chem; 1987 Apr; 30(4):670-5. PubMed ID: 2951522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chiral [16O, 17O, 18O]phosphoric monoesters as stereochemical probes of phosphotransferases.
    Buchwald SL; Hansen DE; Hassett A; Knowles JR
    Methods Enzymol; 1982; 87():279-301. PubMed ID: 6294451
    [No Abstract]   [Full Text] [Related]  

  • 11. Delivery of floxuridine derivatives to cancer cells by water-soluble organometallic cages.
    Yi JW; Barry NP; Furrer MA; Zava O; Dyson PJ; Therrien B; Kim BH
    Bioconjug Chem; 2012 Mar; 23(3):461-71. PubMed ID: 22263930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3'-O- and 5'-O-Propargyl Derivatives of 5-Fluoro-2'-Deoxyuridine: Synthesis, Cytotoxic Evaluation and Conformational Analysis.
    Baraniak D; Baranowski D; Ruszkowski P; Boryski J
    Nucleosides Nucleotides Nucleic Acids; 2016; 35(4):178-94. PubMed ID: 26914155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5'-O-Palmitoyl- and 3',5'-O-dipalmitoyl-5-fluoro-2'-deoxyuridine--novel lipophilic analogues of 5'-fluoro-2'-deoxyuridine: synthesis, incorporation into liposomes and preliminary biological results.
    Schwendener RA; Supersaxo A; Rubas W; Weder HG; Hartmann HR; Schott H; Ziegler A; Hengartner H
    Biochem Biophys Res Commun; 1985 Jan; 126(2):660-6. PubMed ID: 3156589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquisition of human concentrative nucleoside transporter 2 (hcnt2) activity by gene transfer confers sensitivity to fluoropyrimidine nucleosides in drug-resistant leukemia cells.
    Lang TT; Selner M; Young JD; Cass CE
    Mol Pharmacol; 2001 Nov; 60(5):1143-52. PubMed ID: 11641443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of membrane transport of 5-fluoro[6-3H]deoxyuridine into L5178Y mouse leukemia cells.
    Wigler PW; Schluter DN
    Cancer Res; 1976 Sep; 36(9 pt.1):3207-11. PubMed ID: 135641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phospho transfer enzymes: lessons from stereochemistry.
    Knowles JR
    Fed Proc; 1982 Jun; 41(8):2424-31. PubMed ID: 6282653
    [No Abstract]   [Full Text] [Related]  

  • 17. 1-H NMR studies on deuterium-hydrogen exchange at C-5 in uridines.
    Heller SR
    Biochem Biophys Res Commun; 1968 Sep; 32(6):998-1001. PubMed ID: 5723331
    [No Abstract]   [Full Text] [Related]  

  • 18. Cytotoxicity of 5-fluoro-5'-O-nitro-2'-deoxyuridine, a new fluorinated pyrimidine derivative, in L1210 cultures.
    Roberts D; Franklin P; Odom G; Peck C; Chwang TL
    Mol Pharmacol; 1982 Nov; 22(3):760-5. PubMed ID: 6218391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oligonucleotide N-alkylphosphoramidates: synthesis and binding to polynucleotides.
    Jäger A; Levy MJ; Hecht SM
    Biochemistry; 1988 Sep; 27(19):7237-46. PubMed ID: 3264723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cytostatic activity of NUC-3073, a phosphoramidate prodrug of 5-fluoro-2'-deoxyuridine, is independent of activation by thymidine kinase and insensitive to degradation by phosphorolytic enzymes.
    Vande Voorde J; Liekens S; McGuigan C; Murziani PG; Slusarczyk M; Balzarini J
    Biochem Pharmacol; 2011 Sep; 82(5):441-52. PubMed ID: 21658373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.